Company / Tangible Book Value per Share
Sana Biotechnology, Inc. Tangible Book Value per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.48
FY2024
5-year range
-$43.17 / $3.53
FY2020-FY2024
Trend
-37.0%
vs FY2023
Sector context
#175 of 209
Health Care
What the data says
Sana Biotechnology, Inc.'s tangible book value per share of $0.48 is lower than 84% of companies in the Health Care sector (FY2024). Tangible Book Value per Share has declined for 3 consecutive years, from $3.53 in FY2021 to $0.48 in FY2024.
Based on SEC 10-K filings.
0.48 in FY2024 with a 3-year CAGR of -48.7%.
Declined from $1.90 to $0.48 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -48.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.5% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2024, tangible book value per share decreased 37.0% year-over-year.
- Ranks #175 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.48 | -37.0% |
| FY2023 | $0.76 | -60.4% |
| FY2022 | $1.90 | -46.1% |
| FY2021 | $3.53 | +108.2% |
| FY2020 | -$43.17 | -48.5% |
| FY2019 | -$29.07 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026